Frontiers
Inactive· since Mar 23, 2026
- 80
- days it ran
- 0
- relaunches
- 3,944
- EU reach
Ad copy
Tumour hypoxia drives therapy resistance by rewiring immune cells, cancer-associated fibroblasts, and the extracellular matrix, argue the authors of this article in Frontiers in Oncology (Impact Factor 3.3). The article already has more than 20k views and downloads and 81 citations. Read now ⬇️
Read now: Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours
Hypoxia is a common feature of solid tumours affecting their biology and response to therapy. Key to this is the hypoxia-inducible factor (HIF), orchestratin...
LEARN MORE🪄Crush AI
Like this ad? Make it yours.
Crush rebuilds this exact creative around your product — your brand, your colors, your offer — in about a minute.
